ID

15746

Description

Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01697631

Link

https://clinicaltrials.gov/show/NCT01697631

Keywords

  1. 6/10/16 6/10/16 -
Uploaded on

June 10, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes NCT01697631

Eligibility Diabetes NCT01697631

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01697631
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Description

type 2 diabetes

Data type

boolean

Alias
UMLS CUI [1]
C0011860
current treatment with conventional biphasic human insulin 30/70 b.i.d. (twice daily) for at least 3 months
Description

conventional biphasic human insulin

Data type

boolean

Alias
UMLS CUI [1]
C0356369
hba1c (glycosylated haemoglobin) equal to or below 12%
Description

hba1c

Data type

boolean

Alias
UMLS CUI [1]
C0019018
willing and able to perform self blood glucose monitoring (smbg)
Description

self blood glucose monitoring

Data type

boolean

Alias
UMLS CUI [1]
C0005803
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of drug or alcohol dependence
Description

drug or alcohol dependence

Data type

boolean

Alias
UMLS CUI [1]
C0038586
mental incapacity, unwillingness or language barriers precluding adequate understanding or co-operation
Description

language barriers

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0162340
previous participation in this trial
Description

previous participation in this trial

Data type

boolean

Alias
UMLS CUI [1]
C2348568
receipt of any investigational drug within the last month prior to this trial
Description

investigational drug

Data type

boolean

Alias
UMLS CUI [1]
C2348568
known or suspected allergy to trial products or related products
Description

allergy to trial products

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3854006

Similar models

Eligibility Diabetes NCT01697631

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01697631
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
type 2 diabetes
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
conventional biphasic human insulin
Item
current treatment with conventional biphasic human insulin 30/70 b.i.d. (twice daily) for at least 3 months
boolean
C0356369 (UMLS CUI [1])
hba1c
Item
hba1c (glycosylated haemoglobin) equal to or below 12%
boolean
C0019018 (UMLS CUI [1])
self blood glucose monitoring
Item
willing and able to perform self blood glucose monitoring (smbg)
boolean
C0005803 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
drug or alcohol dependence
Item
history of drug or alcohol dependence
boolean
C0038586 (UMLS CUI [1])
language barriers
Item
mental incapacity, unwillingness or language barriers precluding adequate understanding or co-operation
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
previous participation in this trial
Item
previous participation in this trial
boolean
C2348568 (UMLS CUI [1])
investigational drug
Item
receipt of any investigational drug within the last month prior to this trial
boolean
C2348568 (UMLS CUI [1])
allergy to trial products
Item
known or suspected allergy to trial products or related products
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial